ISDS Case Map
medicines
There’s a debate raging over Canada’s intellectual property regime. If one side’s right, Canada stands to pay $2.8 billion more every year in drug costs while it undermines its generic-drug manufacturing sector.
As the South Korea-United States Free Trade Agreement (KORUS FTA) takes effects Thursday, some are expecting new trade pressures from the US, including moves to open the beef market. In particular, South Korea will be forced to sit down at the negotiating table if the US requests negotiations on beef.
With just days left before the implementation of the US-Korea free trade agreement Washington is drawing attention to a little publicized area of the trade treaty, the part covering the pricing of medicine in Korea. The US says it wants more transparency; the Korean pharmaceutical industry says it wants to maintain control over pricing domestically.
Negotiations of the Transpacific Partnership Agreement (TPP) have turned to discussions of the pharmaceutical reimbursement chapter. This issue is highly controversial and represents a very recent shift in US trade policy.
After four years of negotiations, campaigners fear India is about to sign a trade deal with the EU which will stop the flow of cheap life-saving drugs to the developing world
Supporting the ongoing Global Week of Action on the EU-India FTA, Pauline Londeix of Act Up-Paris today confronted the European Commission for Trade, Karel de Gucht at a “Civil Society dialogue on Trade, Growth and development” at the European Commission. De Gucht reportedly leaves for India tomorrow for the EU-India Summit on 10th February 2012 where the E.C. is putting pressure on the Indian government to announce political trade-offs in the EU-India FTA.
Fiji Network for Positive People believes that the Asia Pacific Network of People Living with HIV/AIDS meeting will be an opportune time to advocate for continuing availability of generic Anti Retro Viral treatment in the face of threats from Free Trade Agreement negotiations.
Under the Korea-US Free Trade Agreement (KORUS FTA), Korean civil servants would be excluded from the Health Insurance Review and Assessment Service (HIRA)’s process of price determination. Instead independent review procedures could be used to set prices for medicines and medical supplies. This has caused concern among health care groups who worry that multinational pharmaceutical companies could use the independent review procedure to change the Korean government’s medicine prices.
As the 14th round of negotiations on the EU-India free trade agreement is held in Delhi, an NGO working in the health sector has urged the European Union not to push India to accept IP provisions in the deal
DNP+ believes that IP should be completely be removed from the trade
negotiations.
